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Health evaluation and referral assistant: 
a randomized controlled trial to improve 
smoking cessation among emergency 
department patients
Edwin D. Boudreaux1*, Beau Abar2, Brianna Haskins3, Brigitte Bauman4 and Grant Grissom5
Abstract 
Background: Computer technologies hold promise for implementing tobacco screening, brief intervention, and 
referral to treatment (SBIRT). This study aims to evaluate a computerized tobacco SBIRT system called the Health 
Evaluation and Referral Assistant (HERA).
Methods: Smokers (n = 421) presenting to an emergency department were randomly assigned to the HERA or a 
minimal-treatment Control and were followed for 3 months. Analyses compared smoking cessation treatment pro-
vider contact, treatment initiation, treatment completion, and smoking behavior across condition using univariable 
comparisons, generalized estimating equations (GEE), and post hoc Chi square analyses.
Results: HERA participants were more likely to initiate contact with a treatment provider but did not differ on treat-
ment initiation, quit attempts, or sustained abstinence. Subanalyses revealed HERA participants who accepted a faxed 
referral were more likely to initiate treatment but were not more likely to stop smoking.
Conclusions: The HERA promoted initial contact with a smoking cessation provider and the faxed referral further 
promoted treatment initiation, but it did not lead to improved abstinence.
Trial registration: ClinicalTrials.gov number NCT01153373
Keywords: Tobacco, Brief intervention, Emergency medicine, Facilitated referral, Tobacco treatment, Tobacco 
screening
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Background
Each year tobacco use kills 430,000 Americans for an 
average of over 5 million years of potential life lost annu-
ally [1–4]. Smoking cessation is a cost-effective disease 
prevention strategy that has shown immediate and sub-
stantive health benefits in those who successfully quit 
[3]. While much attention has focused on primary care 
as a setting to promote smoking cessation, hospital 
emergency departments (EDs) are uniquely positioned 
for tobacco intervention efforts as well. The prevalence 
of tobacco use among ED patients exceeds the national 
average [2, 5, 6], with a 2014 study reporting an overall 
prevalence of more than double the national average [5]. 
Furthermore, disadvantaged and underserved popula-
tions, such as minority patients, underinsured, and low 
income households, rely disproportionately upon EDs 
for primary care services [7]. With over 130 million vis-
its annually, ED originated tobacco control efforts have 
the potential for substantial impact on public health by 
effecting change in hard to reach populations [7, 8].
This potential was recognized by the Robert Wood 
Johnson Foundation which recommended implementa-
tion of routine screening, brief intervention, and refer-
ral to treatment (SBIRT) for tobacco in the ED setting, 
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and strongly encouraged research to develop tobacco 
interventions specific to the needs of EDs [7]. Addition-
ally, a joint statement by the American College of Emer-
gency Physicians and the Emergency Nurses Association 
recommended that ED healthcare providers universally 
screen and counsel tobacco users seeking care in the ED. 
They proposed using a brief Ask, Advise, Refer model, 
which consists of Asking about tobacco use, Advising 
patients to quit, and Referring patients to specialized 
treatment for tobacco use [2, 3]. The Ask, Advise, Refer 
model has since been adopted by researchers in their 
work to refine an effective ED-appropriate strategy for 
tobacco SBIRT [9, 10].
While much literature supports the utility of tobacco 
SBIRT for the ED population [2–7, 9–11], questions 
still remain regarding the most effective and appropri-
ate SBIRT protocol. Factors likely to impede clinician 
intervention include competing time demands, lack of 
specialized behavioral health training, and a mission 
centered on acute rather than chronic medical care 
[6–8]. To maximize successful implementation, pro-
cedures should be convenient, brief, require minimum 
specialized training, and focus on connecting patients 
to outpatient resources after the ED visit. Traditional 
strategies typically do not meet all of these require-
ments and result in inconsistent adoption [12]. Behav-
ioral intervention technology advancement has allowed 
for the development of computer-assisted SBIRT mod-
els which aim to reduce interruptions in clinical care 
and reduce clinician burden without sacrificing effec-
tiveness [8].
The objective of this study was to test a new web-based 
program to facilitate tobacco SBIRT called the Health 
Evaluation and Referral Assistant (HERA). The HERA 
was patterned after face-to-face SBIRT models and is 
self-administered by patients on a computer during their 
medical visit. This study tested the hypotheses that the 
HERA would result in greater outpatient smoking ces-
sation treatment initiation and increased smoking ces-
sation over three months post-visit as compared with a 
minimal intervention control condition.
Methods
A full description of the HERA development and RCT 
methods were previously reported [12, 13]. Although 
the HERA assesses for and refers patients to treatment 
for tobacco, alcohol, and illicit drug use, only results per-
taining to tobacco are reported in this paper. Subsequent 
papers will address the other substance classes. This 
clinical trial was registered with ClinicalTrials.gov as the 
Dynamic Assessment and Referral System (ClinicalTrials.
gov Identifier: NCT01153373).
HERA
Assessment The HERA uses the two-item Heavy Smok-
ing Index (HSI) to assess nicotine dependence [14]. Age 
of first smoking cigarettes regularly, use of other forms 
of tobacco, such as cigars or smokeless tobacco, and 
readiness to change were also assessed. Participants 
who expressed interest in quitting were asked when they 
would like to quit (within the next 30  days, Within the 
next 6  months, more than 6  months from now), and if 
they would like help connecting with a smoking cessation 
counselor or treatment program (Yes, No).
A checklist of psychiatric diagnoses was used to docu-
ment psychiatric history [none, anxiety or panic attacks 
or post-traumatic stress disorder (PTSD), depression or 
bipolar disorder, schizophrenia or schizoaffective dis-
order, anorexia or bulimia, attention deficit disorder 
(ADD, ADHD), other]. Participants were also screened 
for depression using the Patient Health Questionaire-2 
(PHQ-2) [15].
Report generator Two reports using the assessment 
data were produced, and are described in detail by 
Boudreaux et al. [12, 13]. The Healthcare Provider Report 
is a summary of the assessment and was reviewed by 
the patient’s treating physician. The Patient Feedback 
Report consisted of three sections: (1) the Face Sheet, 
which included an overview and tailored tobacco refer-
ral list, (2) the Patient Assessment Summary, which pro-
vided personally tailored feedback related to the patient’s 
tobacco use, and (3) the Motivation Toolkit, which con-
sisted of several worksheets rooted in motivational inter-
viewing [16] and the transtheoretical model [17].
Referral generator The referral generator draws upon 
a library of smoking cessation treatment services main-
tained by Polaris Health Directions, Inc. The library is 
used to generate personally tailored referral lists contain-
ing free and fee-for-service treatment options, includ-
ing free state quitlines, and to send dynamic referrals. 
A dynamic referral is a faxed referral to a “best match” 
facility based on the individual’s ZIP code, insurance, and 
desire for telephone or in-person treatment. If accepted 
by the patient, the dynamic referral was faxed by the 
HERA and included a brief assessment summary and the 
patient’s contact information. The participating services 
agreed to contact the individual within 48 h of receiving 
the referral to perform an initial evaluation and explore 
treatment options.
Procedure
Patients were enrolled from four EDs (see Table 1) dur-
ing 8 AM to 7 PM, with shifts representing all days of the 
week. Research assistants (RAs) approached consecutive 
adult patients at their bedside. All patients who smoked 
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within the past 30 days and 18 years or older were con-
sidered. Patients with risky alcohol use or illicit drug 
use, including those who currently demonstrate tobacco 
dependence, were enrolled into the larger trial and exam-
ined separately due to the overarching goal of intervening 
on the most salient/emergent substance-related con-
cerns. The current paper focuses only on tobacco users 
who did not abuse alcohol or use drugs. Exclusion criteria 
included severe illness or distress, cognitive insufficiency, 
in state custody or restraints, being held involuntarily, 
and language barriers. Patients were enrolled regardless 
of whether they were admitted or discharged; the study 
components, including baseline and intervention, were 
completed prior to leaving the ED. Participants were ran-
domized to either the intervention or control condition 
by a random number generator from the Java program-
ming language standard library embedded within the 
HERA. Immediately following discharge/transfer from 
the ED, the enrolling RA completed a short interview 
with the participant, either in person before he or she left 
the ED or by phone within 48 h (post-visit interview). A 
trained RA unaffiliated with the performance sites con-
tacted all participants by telephone at 4 and 12 weeks fol-
lowing the ED visit to assess tobacco treatment initiation 
and to re-assess tobacco use. Biological verification of 
abstinence was not obtained. The study was approved by 
the Institutional Review Boards for all performance sites. 
All participants gave their informed consent and signed a 
written consent form prior to their inclusion in the study.
Study conditions
Intervention and control conditions were treated the 
same in all respects related to study procedures. Those 
in the intervention condition (HERA) (1) were offered a 
dynamic referral, (2) their treating physician was given 
the Healthcare Provider Report, and (3) the patient was 
given the Patient Feedback Report, which included a 
personally tailored referral list. Those assigned to the 
minimal intervention control condition (Control) com-
pleted the HERA assessment but were not offered the 
dynamic referral, and the reports were not made avail-
able to either the healthcare provider or the patient. 
However, Control group patients did receive a standard-
ized, printed list of local smoking cessation treatment 
providers and included the toll-free tobacco quitline 
1-800-QUIT-NOW.
Blinding
The RA performing the outcome assessments was par-
tially blinded. Because the HERA is heavily focused on 
the referral process, and different patients received differ-
ent types of referrals, the follow-up questions were keyed 
to the referral type received at baseline (printed list vs. 
dynamic referral) to avoid confusion. Despite blinding 
efforts, the nature of the questions revealed some infor-
mation about the group assignment if the participant had 
accepted a dynamic referral. For example, only patients 
who chose a dynamic referral were asked whether they 
had been contacted by a smoking cessation counselor.
Measures
HERA The HERA assessment was described under meth-
ods/assessment module.
Post-visit interview Immediately following discharge/
transfer from the ED, the enrolling RA completed a short 
interview to ascertain if the treating clinicians provided 
tobacco counseling, education materials, or referrals for 
tobacco treatment. Chart review was not used because of 
unreliability associated with documenting tasks such as 
counseling.
Follow-up assessment All participants were asked if 
they had made initial contact with a smoking cessation 
counselor or treatment program (treatment contact), 
completed an initial assessment (treatment initiation), 
attended any additional treatment sessions beyond the 
initial assessment (treatment engagement), and com-
pleted treatment (treatment completion). Any of these 
milestones could have occurred in person or by tele-
phone. The RA interviewed the participant by phone to 
assess a self-reported quit attempt defined as intentional 
abstinence for 24 h, efforts to decrease tobacco use, the 
HSI, and sustained abstinence since the ED visit.
Data analyses
In addition to univariable comparisons, the primary 
analysis consisted of a series of generalized estimat-
ing equation (GEE) analyses comparing the control and 
intervention conditions on outcomes of interest (tobacco 
treatment provider contact, treatment initiation, tobacco 
use) during the 4 and 12  week follow-up. When GEE 
models were statistically significant, post hoc Chi square 
Table 1 Site characteristics
W white, non-Hispanic, H Hispanic, B black, U unknown, MA Massachusetts, NJ 
New Jersey
Type Annual 
volume
Location Race/ 
ethnicity
Academic, urban 90,733 Worcester, MA W 82 %, H 11 %, 
B 4 %
Community, urban 47,364 Worcester, MA W 74 %, H 14 %, 
B 9 %
Community,  
suburban
23,217 Marlboro, MA W 80 %, H 15 %, 
B 3 %, U 2 %
Academic, urban 59,482 Camden, NJ W 35 %, H 20 %, 
B 45 %
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analyses were used to provide greater context for the 
observed findings. These models were unconditional 
(i.e., included no covariates) due to random assignment 
equating groups on potential confounding characteris-
tics. A series of planned Chi square analyses were also 
performed for outcome data available at a single time 
point (e.g., ED counseling, treatment completion).
Analyses were supplemented by examining differences 
across individuals in the control condition versus those in 
the intervention condition that accepted a dynamic refer-
ral and those in the intervention (dynamic referral) con-
dition that declined a dynamic referral (tailored list only). 
These supplemental models included baseline HSI and 
readiness to quit as covariates to account for preexisting 
differences between individuals who accept a referral and 
those who do not. All GEE models were performed first 
using multiple imputation with 20 datasets to account 
for missing data at each of the follow-ups. These models 
were then recapitulated under intention-to-treat prin-
ciples (i.e., non-retained participants provided with the 
least favorable outcome), and the patterns of statistical 
significance of primary predictors and covariates were 
identical. Observed frequencies were presented in each 
table, with the percentages representing intention-to-
treat values. An alpha level of 0.05 was used to indicate 
statistical significance for all comparisons, and all analy-
ses were performed using SPSS 22 (IBM, 2012).
Results
Preliminary analysis
Of 600 tobacco users who met eligibility criteria and who 
did not demonstrate risky alcohol and/or drug use, 427 
individuals were enrolled (see Fig.  1). Those enrolled 
were not statistically different across demograph-
ics and enrollment site to those who were not enrolled, 
except enrolled individuals were slightly younger 
(M = 39.5 years; SD = 12.3) than non-enrolled individu-
als (M = 43.0 years; SD = 14.3), t (598) = 2.52, p = 0.01. 
Of the 427 participants enrolled, 215 were assigned to the 
control condition and 212 to the intervention. Six were 
eliminated due to either having been deceased before 
the follow-up assessment was complete or withdrawal 
from the study because of duplicate enrollment, result-
ing in an analyzed sample of 421 participants (211 Con-
trol, 210 HERA). At baseline, there were no differences 
between the two conditions on demographics, mental 
health diagnoses, HSI, pack years, or readiness to change 
(p values >0.10) (Table 2).
Of the 421 analyzed participants, 412 (98 %) completed 
the post-visit interview, 314 (75  %) completed the one-
month follow-up, and 295 (70  %) completed the three-
month follow-up (see Fig.  1). There were no differences 
between retained individuals and those lost to follow-up 
on intervention condition, most demographic charac-
teristics, baseline HSI score, pack years, or readiness to 
change (p values  >0.05); however, retained participants 
were slightly older (M  =  39.8  years; SD  =  12.3) than 
those lost to follow-up (M  =  37.0  years; SD  =  11.7), t 
(419) = 2.18, p = 0.03.
Comparisons on outcomes of interest
Specialized smoking cessation treatment Initial contact 
between participants and a smoking cessation treat-
ment provider was significantly more common in the 
intervention condition than the control condition (odds 
ratio  =  2.69; see Table  3), with significant differences 
observed at each follow-up [1  month χ2 (1)  =  8.16, 
p = 0.004; 3 months χ2 (1) = 11.65, p = 0.001]. Although 
treatment initiation, treatment engagement, and treat-
ment completion rates were higher in the intervention 
condition compared to the control, these differences did 
not reach statistical significance (p values >0.05). Among 
the participants in the HERA, 72 (34  %) accepted a 
dynamic referral.
Tobacco use Quit attempts, efforts to reduce smoking, 
HSI, and sustained abstinence at both follow-up periods 
were not statistically different across intervention and 
control conditions (see Table 3).
Physician behavior Clinician counseling, provision of 
educational materials, and provision of referrals, beyond 
those provided as part of the study protocol, were not 
statistically different across intervention and control con-
ditions (see Table 3).
Exploring the effect of dynamic referrals Supplemen-
tal GEE analyses demonstrated large differences across 
groups on treatment contact. Using dummy codes (con-
trol condition as the reference), results indicated that 
experimental participants who accepted a dynamic 
referral made contact with a provider a much greater 
rate than control individuals (odds ratio  =  11.89, 95  % 
CI 6.70–21.09, p  <  0.001; see Table  4). Effects on treat-
ment initiation were of relatively similar magnitude, 
with much higher rates of initiation among experimental 
participants who accepted a dynamic referral and con-
trol participants (odds ratio =  4.41, 95  % CI 2.11–9.21, 
p  <  0.001). There were no differences in treatment ini-
tiation between experimental individuals who did not 
accept a dynamic referral and control individuals (odds 
ratio  =  0.52, 95  % CI 0.18–1.49, p  =  0.22). The differ-
ences in treatment initiation between experimental par-
ticipants who accepted a dynamic referral and control 
participants remained significant (p values  <0.05) when 
accounting for baseline readiness to change and baseline 
HSI in post hoc GEE models (see Table 5).
There was also a significant effect of group member-
ship on engagement in cessation treatment, χ2 (1) = 6.60, 
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Total HERA Potential Participants
Total Patients Logged
(n = 8,798)
Patient Not Approached
Various Reasons (n = 3,218)
Too Sick = 1,386
Language Barrier = 112
Patient Distressed/ Hostile/ 
Agitated = 49
Patient Declined = 29
Transient Residence/Lack of 
Telephone = 4
Missed (e.g., Patient Transferred, 
Discharged) = 1017
Shift Ended Before Seen = 335
Other Reasons = 286
Patient Not Screened
Various Reasons 
(n =1,311)
Too Sick = 381
Language Barrier = 265
Patient Distressed/ Hostile/ 
Agitated = 65
Patient Declined = 308
Transient Residence/Lack of 
Telephone = 43
Missed (e.g., Patient 
Transferred, Discharged) = 
192
Shift Ended Before Seen = 8
Other Reasons = 49
Patient Approached
(n = 5,580)
Patient Screened Negative
(n = 2,718)
Patient Screened Positive
(n = 1,551)Patient Not Enrolled(n = 545)
Too Sick = 37
Language Barrier = 9
Patient Distressed/ Hostile/ 
Agitated = 8
Patient Declined = 320
Transient Residence/Lack of 
Telephone = 122
Missed (e.g., Patient Transferred, 
Discharged) = 7
Other Reasons = 42
Patient Enrolled
(n = 427)
n = 158 retained at 
1-month follow-up
n = 146 retained at 
3-month follow-up
n = 156 retained at 
1-month follow-up
n = 149 retained at 
3-month follow-up
Patient Enrolled in 
Other Arms of the Project
(n = 579)
Alcohol Abuse = 212
Drug Abuse = 367
Intervention
Participants
(n = 212)
Control 
Participants
(n = 215)
Fig. 1 Enrollment flow for the HERA RCT—tobacco
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Table 2 Demographic characteristics of the analyzed sample
Risky alcohol and illicit drug users were excluded from the tobacco sample; they were enrolled and randomized into the alcohol and drug use samples, to be reported 
separately
a Insurance status categories are not mutually exclusive (i.e. participants can have multiple types of insurance)
b Only participants in the intervention condition. All patients in the intervention group received the tailored, printed list of providers by default. Dynamic referral 
consists of a faxed referral with a brief tobacco use summary to a tobacco treatment provider matched to the individual based on location of residence and preference 
for telephone vs. in-person treatment. All patients in the intervention group received the tailored, printed list of providers by default
Frequency % Mean Standard deviation
Participant sex
 Male 150 35.6 %
 Female 271 64.4 %
Participant age 39.0 12.2
Data collection site
 Cooper University Hospital (NJ) 233 55.3 %
 UMass University Hospital (MA) 178 42.3 %
 UMass Memorial Hospital (MA) 4 1.0 %
 Marlborough Hospital (MA) 6 1.4 %
Race
 White 291 69.1 %
 Black 114 27.1 %
 Other/undocumented 16 3.8 %
Ethnicity
 Non-hispanic/Latino 339 80.5 %
 Hispanic/Latino 67 15.9 %
 Not documented 15 3.6 %
Insurance statusa
 Private insurance 80 19.0 %
 Medicaid 127 30.2 %
 State financed insurance—non-medicaid 78 18.5 %
 Medicare 69 16.4 %
 Other kind of insurance not listed 27 6.4 %
 No insurance 73 17.3 %
PHQ-2 1.7 1.7
Any mental health diagnosis 240 57.0 %
 Anxiety/panic attacks/PTSD 158 37.5 %
 Depression/bipolar disorder 150 35.6 %
 Schizophrenia/schizoaffective disorder 12 2.9 %
 Anorexia/bulimia 4 1.0 %
 ADD/ADHD 29 6.9 %
 Other mental health diagnosis 17 4.0 %
Baseline HSI score 2.5 1.4
Pack years 18.2 14.9
Other tobacco used in past 30 days
 Cigars 14 3.3 %
 Smokeless tobacco (Dip, Snuff, Chew) 2 0.5 %
Experimental condition
 Intervention 210 49.9 %
 Control 211 50.1 %
Referralb
 Tailored, printed list of providers (only) 138 65.7 %
 Dynamic referral accepted 72 34.3 %
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p = 0.037 (see Table 4). While engagement was relatively 
infrequent across all groups, the rate of engagement for 
those accepting a dynamic referral was more than double 
the rate observed in the control condition (8.3 vs. 3.3 %; 
see Table 4). This effect, however, was no longer signifi-
cant when baseline readiness to change tobacco use and 
HSI were included as covariates (odds ratio control vs. 
tailored list only  =  0.78, 95  % CI 0.19–3.18, p  =  0.73; 
odds ratio control vs. dynamic referral =  1.83, 95  % CI 
0.58–5.76, p  =  0.30). There were no effects of group 
membership on tobacco cessation (see Tables 4 and 5).
Discussion
Providing tobacco interventions in the ED is important 
because many patients treated in EDs do not receive care 
anywhere else, which makes this setting important for 
comprehensive public health efforts to improve tobacco 
cessation [18]. However, there are unique barriers that 
make incorporating interventions into routine clini-
cal care difficult, including competing priorities, time 
demands, acute care scope of practice, and a lack of clini-
cian training related to smoking cessation interventions. 
As a result, technology facilitated interventions may be 
a particularly good fit. The results of this clinical trial 
studying a novel, single administration, stand-alone com-
puterized intervention were mixed. Overall, the results 
suggested that the HERA may improve the critical step 
of initiating contact with an outpatient smoking cessation 
treatment provider after the ED visit, with the dynamic 
referral further promoting the next step of treatment 
initiation, but these effects do not translate into con-
tinued engagement in treatment or changes in smoking 
behavior over the 3  months following the ED visit. The 
low engagement rates of the HERA are consistent with 
rates from a similar study by Willet et  al. to investigate 
the utility of faxed referrals to promote engagement with 
tobacco quitlines [19].
Factors that may have affected the HERA’s impact 
upon treatment and smoking cessation include lack 
of supportive efforts by ED staff, the low intensity of 
the HERA intervention, and barriers to patient follow 
through after contact with a smoking cessation treat-
ment provider. It was deployed largely as a stand-alone 
intervention, because the practical realities of current ED 
practice suggested this would be the model most likely to 
be used in the ED environment. Although the clinicians 
who received the Healthcare Provider Report were edu-
cated on how to interpret the findings, and it could have 
prompted them to provide counseling to the patient, 
they were not specifically trained or mandated to provide 
counseling or any additional intervention materials. The 
analyses showed that, in fact, the intervention group did 
not receive any additional counseling or smoking cessa-
tion materials from their treating clinicians. A study of 
ED-based multicomponent intervention for tobacco use 
by Bernstein et al. [20] found that patients who received 
enhanced care in a variety of forms, including clinician 
counseling, nicotine patches, and follow-up phone call, 
were more likely to be abstinent at 3 months than those 
receiving standard referral. Greater clinician involvement 
may be needed to increase abstinence.
The HERA was a one-time interaction designed to be 
brief out of sensitivity to the time demands in the ED. 
This could have adversely affected its clinical impact. 
Future technology interventions may need to incorpo-
rate more powerful motivational interventions, such as 
interactive multi-media content, and longitudinal inter-
action after the ED visit. Longitudinal computerized 
interventions that provide personalized feedback reports 
over time have demonstrated evidence of effectiveness 
Table 3 Comparisons between  intervention and  control 
conditions
All percentages and analyses use the ITT principal of worst outcome for missing 
values
a ED clinician behavior assessment included behaviors over and above the 
materials provided as part of the research study. All patients in both groups had 
tobacco assessed as part of the study and received a referral list. The control 
group received a pre-printed list, while the intervention group received a 
personally tailored list, as well as a dynamic referral if desired
Intervention
(n = 210)
Control
(n = 211)
ED clinician (MD/RN) counselinga
 MD/RN asked about tobacco use 172 (81.9 %) 165 (78.2 %)
 MD/RN counseled participant to quit 73 (34.8 %) 68 (32.2 %)
 Received educational materials 8 (3.8 %) 14 (6.6 %)
 Received a smoking cessation referral 5 (2.4 %) 11 (5.2 %)
Outpatient smoking cessation treatment
 Contact with tobacco treatment provider
 GEE odds ratio = 2.69 (95 % CI 1.65–4.39), p < 0.001
  Contact at 1 month 35 (16.7 %) 16 (7.6 %)
  Contact at 3 months 48 (22.9 %) 27 (12.8 %)
 Initiated treatment (evaluated by tobacco treatment provider)
 GEE odds ratio = 1.69 (95 % CI 0.86–3.31), p = 0.13
  Treatment initiation at 1 month 10 (4.8 %) 8 (3.8 %)
  Treatment initiation at 3 months 21 (10.0 %) 14 (6.6 %)
 Treatment engagement at either time 8 (3.8 %) 7 (3.3 %)
 Treatment completion 7 (3.3 %) 6 (2.8 %)
Smoking behavior
 Used tobacco (since ED visit)
 GEE odds ratio = 0.98 (95 % CI 0.62–1.55), p = 0.93
 Abstinent for first month (since visit) 13 (6.2 %) 19 (9.0 %)
 Abstinent for 3 months (since visit) 8 (3.8 %) 9 (4.3 %)
 At least one quit attempt at 1 month 68 (32.4 %) 72 (34.1 %)
 At least one quit attempt at 3 months 105 (50.0 %) 118 (55.9 %)
 Attempted to reduce use at 1 month 125 (59.5 %) 122 (57.8 %)
 Attempted to reduce use at 3 months 150 (71.4 %) 154 (73.0 %)
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in several well-controlled trials, such as the Tobacco 
Expert System [21–23]. Blending the report generating 
and dynamic referral capabilities of the HERA with the 
longitudinal support and monitoring of systems like the 
Tobacco Expert System may represent the next evolution 
in technology facilitated tobacco interventions.
The HERA may not have promoted treatment initiation 
and engagement because other insurmountable barriers 
might have been present. For example, even for an indi-
vidual who is highly motivated and successfully connects 
with a smoking cessation treatment provider, attending 
in-person counseling sessions can be impossible if he or 
she does not have transportation, has young children but 
no access to childcare, or works during hours when the 
services are available [7]. Moreover, some smoking cessa-
tion services charge a fee, which may have been prohibi-
tive for some patients. Individuals were offered a toll-free 
telephone counseling option through the tobacco quitline 
1-800-QUIT-NOW  to help address cost and inconven-
ience barriers, but this may not have been sufficient to 
account for all barriers.
Limitations
Several limitations affect interpretation of the findings. 
The study did not use biochemical validation of smok-
ing abstinence. The impact on interpretation is likely to 
be minimal, because a treatment effect on smoking status 
was not observed. A minimal treatment control group 
was used, rather than true treatment as usual. The assess-
ment and resource list may have acted as an intervention 
and artificially inflated treatment contact and behavior 
change compared to true treatment as usual. The study 
enrolled ED patients, which have been shown to change 
their smoking behavior after the ED visit naturalistically, 
especially when they perceived their visit to be smoking-
related [7, 24–26]. It is particularly difficult to extend an 
intervention effect beyond this natural change motiva-
tor of the visit itself. Costs associated with the treatment 
services may have been a barrier to treatment initiation 
and engagement, but were partially mitigated by the 
inclusion of free treatment options in addition to the 
Table 4 Comparisons across intervention, tailored list only; intervention, dynamic referral; and control conditions
Intervention-provider list
(n = 138)
Intervention-dynamic referral
(n = 72)
Control
(n = 211)
Outpatient smoking cessation treatment
 Contact with tobacco treatment provider
 Contact at 1 month 3 (2.0 %) 32 (44.4 %) 16 (7.6 %)
 Contact at 3 months 6 (4.3 %) 42 (58.3 %) 27 (12.8 %)
Initiated treatment (evaluated by tobacco treatment provider)
  Treatment initiation at 1 month 2 (1.4 %) 8 (11.1 %) 8 (3.8 %)
  Treatment initiation at 3 months 3 (2.2 %) 18 (25.0 %) 14 (6.6 %)
Treatment engagement, either time 2 (1.4 %) 6 (8.3 %) 7 (3.3 %)
Treatment completion 2 (1.4 %) 5 (6.9 %) 6 (2.8 %)
Tobacco cessation
 Abstinent for first month (since visit) 10 (7.2 %) 3 (4.2 %) 19 (9.0 %)
 Abstinent for 3 months (since visit) 6 (4.3 %) 2 (2.8 %) 9 (4.3 %)
 At least one quit attempt at 1 month 47 (34.1 %) 21 (29.2 %) 72 (34.1 %)
 At least one quit attempt at 3 months 72 (52.2 %) 33 (45.8 %) 118 (55.9 %)
 Attempted to reduce use at 1 month 80 (58.0 %) 45 (62.5 %) 122 (57.8 %)
 Attempted to reduce use at 3 months 98 (71.0 %) 52 (72.2 %) 154 (73.0 %)
Table 5 Follow-up GEE results with covariates
DR dynamic referral
Predictor Odds ratio  
(95 % CI)
p value
Treatment 
contact
Heavy Smoking Index 1.13 (0.90–1.140) 0.29
Readiness to quit 1.21 (0.84–1.75) 0.30
Intervention (list) vs. control 0.61 (0.27–1.41) 0.25
Intervention (DR) vs. control 10.96 (6.12–19.61) <0.001
Treatment 
initiation
Heavy Smoking Index 1.16 (0.85–1.59) 0.34
Readiness to quit 1.60 (0.87–2.94) 0.13
Intervention (list) vs. control 0.61 (0.20–1.85) 0.38
Intervention (DR) vs. control 3.74 (1.79–7.81) <0.001
Abstinence Heavy Smoking Index 0.90 (0.74–1.08) 0.26
Readiness to quit 1.10 (0.83–1.45) 0.51
Intervention (list) vs. control 1.06 (0.61–1.86) 0.82
Intervention (DR) vs. control 0.82 (0.36–1.85) 0.62
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fee-for-service selections. Furthermore, some evidence 
suggests cost does influence follow-up with smoking ces-
sation treatment referrals [27]. The study was also lim-
ited because participants were not questioned about why 
they failed to initiate or remain engaged with treatment 
after receiving the referral, and such barriers should be 
explored in future studies of this or similar systems. By 
focusing solely on tobacco users who do not abuse alco-
hol and/or drugs, the generalizability of our findings is 
somewhat limited. Future research should seek to exam-
ine the efficacy of automated referral generation systems 
for tobacco cessation among all tobacco users. Finally, the 
study follow-up period was limited to 3 months because 
of the restrictions associated with the NIH SBIR/STTR 
funding mechanism.
Conclusion
The HERA helps to satisfy clinical practice mandates to 
Ask, Advise, and Refer tobacco users in the ED setting and 
was effective at promoting initial contact with a tobacco 
treatment provider. The dynamic referral option further 
promoted treatment initiation. However, the HERA, 
when deployed as a stand-alone intervention, did not lead 
to sustained post-visit tobacco treatment engagement or 
changes in smoking behavior within 3  months after the 
ED visit. The results raise the question of whether the 
Ask, Advise, and Refer method is adequate for all popu-
lations, particularly those discouraged by, or unable to 
pay, fees associated with treatment services or those with 
a lack of access to healthcare, which were represented by 
this study. The study highlights the importance of devel-
oping and studying interventions that work in conjunc-
tion with tobacco treatment linkage strategies.
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